Braconi L, Riganti C, Parenti A, Cecchi M, Nocentini A, Bartolucci G
Molecules. 2024; 29(14).
PMID: 39064868
PMC: 11279465.
DOI: 10.3390/molecules29143290.
Wang P, Chen B, Huang Y, Li J, Cao D, Chen Z
Heliyon. 2024; 10(2):e23203.
PMID: 38312641
PMC: 10834481.
DOI: 10.1016/j.heliyon.2023.e23203.
Kim H, Hong J
Pharmaceutics. 2024; 16(1).
PMID: 38258089
PMC: 10820580.
DOI: 10.3390/pharmaceutics16010078.
Sheikh A, Altaf R, Nadeem H, Khan M, Murtaza B
Heliyon. 2023; 9(11):e22183.
PMID: 38053851
PMC: 10694180.
DOI: 10.1016/j.heliyon.2023.e22183.
Sufian M, Zamanova S, Shabana A, Kemp B, Mondal U, Supuran C
Int J Mol Sci. 2023; 24(5).
PMID: 36902027
PMC: 10002582.
DOI: 10.3390/ijms24054595.
A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer.
Zhang Z, Wu B, Shao Y, Chen Y, Wang D
PLoS One. 2022; 17(12):e0278556.
PMID: 36542612
PMC: 9770376.
DOI: 10.1371/journal.pone.0278556.
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells.
Braconi L, Teodori E, Riganti C, Coronnello M, Nocentini A, Bartolucci G
J Med Chem. 2022; 65(21):14655-14672.
PMID: 36269278
PMC: 9661477.
DOI: 10.1021/acs.jmedchem.2c01175.
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
Hiepp L, Mayr D, Gartner K, Schmoeckel E, Klauschen F, Burges A
PLoS One. 2022; 17(7):e0271630.
PMID: 35901081
PMC: 9333239.
DOI: 10.1371/journal.pone.0271630.
Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.
Tonissen K, Poulsen S
Cancer Drug Resist. 2022; 4(2):343-355.
PMID: 35582034
PMC: 9019264.
DOI: 10.20517/cdr.2020.110.
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.
Kciuk M, Gielecinska A, Mujwar S, Mojzych M, Marciniak B, Drozda R
J Enzyme Inhib Med Chem. 2022; 37(1):1278-1298.
PMID: 35506234
PMC: 9090362.
DOI: 10.1080/14756366.2022.2052868.
NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.
Kolawole O, Kashfi K
Int J Mol Sci. 2022; 23(3).
PMID: 35163356
PMC: 8836048.
DOI: 10.3390/ijms23031432.
Post-translational modifications in tumor-associated carbonic anhydrases.
Di Fiore A, Supuran C, Scaloni A, De Simone G
Amino Acids. 2021; 54(4):543-558.
PMID: 34436666
DOI: 10.1007/s00726-021-03063-y.
PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal U, Doroba K, Shabana A, Adelberg R, Alam M, Supuran C
Int J Mol Sci. 2021; 22(3).
PMID: 33498779
PMC: 7866101.
DOI: 10.3390/ijms22031120.
The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells.
Marton E, Varga A, Szeles L, Goczi L, Penyige A, Nagy B
Int J Mol Sci. 2021; 21(24).
PMID: 33419253
PMC: 7766742.
DOI: 10.3390/ijms21249725.
Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.
Langella E, Buonanno M, De Simone G, Monti S
Cell Mol Life Sci. 2020; 78(5):2059-2067.
PMID: 33201250
PMC: 11072538.
DOI: 10.1007/s00018-020-03697-3.
Synthetic Strategies and Computational Inhibition Activity Study for Triazinyl-Substituted Benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Carbonic Anhydrases.
Mikulova M, Kruzlicova D, Pecher D, Supuran C, Mikus P
Int J Mol Sci. 2020; 21(10).
PMID: 32456080
PMC: 7279466.
DOI: 10.3390/ijms21103661.
TFAP2C regulates carbonic anhydrase XII in human breast cancer.
Franke C, Gu V, Grimm B, Cassady V, White J, Weigel R
Oncogene. 2019; 39(6):1290-1301.
PMID: 31636386
DOI: 10.1038/s41388-019-1062-5.
Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration.
Hwang S, Shin D, Hong J
Molecules. 2019; 24(18).
PMID: 31546841
PMC: 6767608.
DOI: 10.3390/molecules24183409.
Carbonic anhydrases as disease markers.
Zamanova S, Shabana A, Mondal U, Ilies M
Expert Opin Ther Pat. 2019; 29(7):509-533.
PMID: 31172829
PMC: 6612586.
DOI: 10.1080/13543776.2019.1629419.
High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
Bi C, Liu M, Rong W, Wu F, Zhang Y, Lin S
BMC Cancer. 2019; 19(1):213.
PMID: 30849962
PMC: 6408801.
DOI: 10.1186/s12885-019-5429-3.